No influence of tumor growth by intramuscular injection of hepatocyte growth factor plasmid DNA: Safety evaluation of therapeutic angiogenesis gene therapy in mice

Biochemical and Biophysical Research Communications

Volumn 315, Issue 1, 2004, Pages 59-65

  Matsuki, Atsushi ^a,b   Yamamoto, Seiji ^a   Nakagami, Hironori ^a   Aoki, Motokuni ^a   Tamai, Katsuto ^a   Matsumoto, Kunio ^a   Nakamura, Toshikazu ^a   Ogihara, Toshio ^a   Kaneda, Yasufumi ^a   Morishita, Ryuichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Angiogenesis; Cancer; Gene therapy; Peripheral vascular disease; Safety

Indexed keywords

PLASMID DNA; SCATTER FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTERY DISEASE; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG MUSCLE LEVEL; EVALUATION; GENE THERAPY; IN VITRO STUDY; INOCULATION; ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SAFETY; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

ANIMALIA;

EID: 10744229619     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.026     Document Type: Article

References (31)

1. Second European Consensus Document on Chronic Critical Leg Ischemia, Circulation 84 (1991) IV 1-26.
2. Isner J.M., Walsh K., Symes J., Pieczek A., Takeshita S., Lowry J., Rosenfield K., Weir L., Brogi E., Jurayj D. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum. Gene Ther. 7:1996;959-988.
3. Baumgartner I., Pieczek A., Manor O., Blair R., Kearney M., Walsh K., Isner J.M. Constitutive expression of phVEGF165 after intramuscularly gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation. 97:1998;1114-1123.
4. Losordo D.W., Vale P.R., Symes J.F., Dunnington C.H., Esakof D.D., Maysky M., Ashare A.B., Lathi K., Isner J.M. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation. 98:1998;2800-2804.
5. Nakamura T., Nishizawa T., Hagiya M., Seki T., Shimonishi M., Sugimura A., Tashiro K., Shimizu S. Molecular cloning and expression of human hepatocyte growth factor. Nature. 342:1989;440-443.
6. Nakamura Y., Morishita R., Nakamura S., Aoki M., Moriguchi A., Matsumoto K., Nakamura T., Higaki J., Ogihara T. A vascular modulator, hepatocyte growth factor, is associated with systolic pressure. Hypertension. 28:1996;409-413.
7. Nakamura Y., Morishita R., Higaki J., Kida I., Aoki M., Moriguchi A., Yamada K., Hayashi S., Yo Y., Nakano H., Matsumoto K., Nakamura T., Ogihara T. Hepatocyte growth factor is a novel member of the endothelium-specific growth factors: additive stimulatory effect of hepatocyte growth factor with basic fibroblast growth factor but not with vascular endothelial growth factor. J. Hypertens. 14:1996;1067-1072.
8. Hayashi S., Morishita R., Higaki J., Aoki M., Moriguchi A., Kida I., Yoshiki S., Matsumoto K., Nakamura T., Kaneda Y., Ogihara T. Autocrine-paracrine effects of overexpression of hepatocyte growth factor gene on growth of endothelial cells. Biochem. Biophys. Res. Commun. 220:1996;539-545.
9. Morishita R., Nakamura S., Hayashi S., Taniyama Y., Moriguchi A., Nagano T., Taiji M., Noguchi H., Takeshita S., Matsumoto K., Nakamura T., Higaki J., Ogihara T. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension. 33:1999;1379-1384.
10. Van Belle E., Witzenbichler B., Chen D., Silver M., Chang L., Schwall R., Isner J.M. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation. 97:1998;381-390.
11. Gherardi E., Sharpe M., Lane K., Sirulnik A., Stoker M. Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells. Symp. Soc. Exp. Biol. 47:1993;163-181.
12. Matsumoto K., Nakamura T. Hepatocyte growth factor: molecular structure, roles in liver regeneration, and other biological functions. Crit. Rev. Oncogenesis. 3:1992;27-54.
13. Rubin J.S., Bottaro D.P., Aaronson S.A. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim. Biophys. Acta. 1155:1993;357-371.
14. Sonnenberg E., Meyer D., Weidner K.M., Birchmeier C. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123:1993;223-235.
15. Stoker M., Gherardi E., Perryman M., Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature. 327:1987;239-242.
16. Cooper C.S., Park M., Blair D.G., Tainsky M.A., Huebner K., Croce C.M., Vande Woude G.F. Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature. 311:1984;29-33.
17. Park M., Dean M., Kaul K., Braun M.J., Gonda M.A., Vande Woude G. Sequence of MET protooncogene cDNA has features characteristic of the tyrosine kinase family of growth-factor receptors. Proc. Natl. Acad. Sci. USA. 84:1987;6379-6383.
18. Bellusci S., Moens G., Gaudino G., Comoglio P., Nakamura T., Thiery J.P., Jouanneau J. Creation of an hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene. 9:1994;1091-1099.
19. Rosen E.M., Knesel J., Goldberg I.D., Jin L., Bhargava M., Joseph A., Zitnik R., Wines J., Kelley M., Rockwell S. Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int. J. Cancer. 57:1994;706-714.
20. Weidner K.M., Behrens J., Vandekerckhove J., Birchmeier W. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells. J. Cell Biol. 111:1990;2097-2108.
21. Nakamura T., Matsumoto K., Kiritoshi A., Tano Y. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res. 57:1997;3305-3313.
22. Date K., Matsumoto K., Kuba K., Shimura H., Tanaka M., Nakamura T. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene. 17:1998;3045-3054.
23. Jiang W., Hiscox S., Matsumoto K., Nakamura T. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit. Rev. Oncol. Hematol. 29:1999;209-248.
24. Taniyama Y., Morishita R., Aoki M., Nakagami H., Yamamoto K., Yamazaki K., Matsumoto K., Nakamura T., Kaneda Y., Ogihara T. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease. Gene Ther. 8:2001;181-189.
25. Couffinhal T., Silver M., Zheng L.P., Kearney M., Witzenbichler B., Isner J.M. Mouse model of angiogenesis. Am. J. Pathol. 152:1998;1667-1679.
26. Yamada A., Matsumoto K., Iwanari H., Sekiguchi K., Kawata S., Matsuzawa Y., Nakamura T. Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed. Res. 16:1995;105-114.
27. Tsurumi Y., Kearney M., Chen D., Silver M., Takeshita S., Yang J., Symes J.F., Isner J.M. Treatment of acute limb ischemia by intramuscularly injection of vascular endothelial growth factor gene. Circulation. 96:1997;II-382-II-388.
28. Tsujie M., Isaka Y., Nakamura H., Imai E., Hori M. Electroporation- mediated gene transfer that targets glomeruli. J. Am. Soc. Nephrol. 12:2001;949-954.
29. Rong S., Bodescot M., Blair D., Dunn J., Nakamura T., Mizuno K., Park M., Chan A., Aaronson S., Vande Woude G.F. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol. Cell. Biol. 12:1992;5152-5158.
30. Takayama H., LaRochelle W.J., Sharp R., Otsuka T., Kriebel P., Anver M., Aaronson S.A., Merlino G. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc. Natl. Acad. Sci. USA. 94:1997;701-706.
31. Isner J.M., Baumgartner I., Rauh G., Schainfeld R., Blair R., Manor O., Razvi S., Symes J.F. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscularly gene transfer of vascular endothelial growth factor: preliminary clinical results. J. Vasc. Surg. 28:1998;964-973.